LGLinda M. Gerber

Linda M. Gerber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Linda M. Gerber has a total of 194 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hot flashes and night sweats in relation to trouble sleeping and daytime sleepiness

    by Lynnette Leidy Sievert, Sofiya Shreyer, Mohamud A. Verjee, Linda M. Gerber

    Objectives: The purpose of this study was to determine whether self-reported night sweats (NS) and hot flashes (HF) were differentially associated with sleep problems, assessed by “trouble sleeping” on a symptom checklist and the Sleep Habits Questionnaire (SHQ), or with the degree of daytime fatigue, assessed by “lack of energy” on a symptom checklist and the Epworth Sleepiness Scale (ESS). Methods: Data were drawn from a study of midlife women aged 40-60 in Doha, Qatar (N=841). Participants were categorized as having (1) neither HF nor NS, (2) only HF, (3) only NS, or (4) both HF and NS. Bivariate analyses using χ 2 and ANOVA were conducted, followed by logistic and linear regression analyses. Results: Women with both HF and NS scored significantly higher on the SHQ than those with neither HF nor NS (16.3 vs. 12.6, P <0.001). In contrast, mean ESS did not differ by HF/NS category. Among women with only NS, the odds of reporting trouble sleeping were almost twice as high (adjusted odds ratio [OR]: 1.78, 95% CI: 1.11-2.84), and the odds of reporting lack of energy were more than two times higher (adjusted OR: 2.63, 95% CI: 1.48-4.68), compared with women reporting neither HF nor NS, after controlling for menopausal status, age, depressed mood, aches/stiffness in joints, education, and nationality. Women reporting only HF did not differ significantly from those reporting neither HF nor NS in relation to lack of energy or trouble sleeping. Conclusions: These findings suggest that NS are more disruptive to women’s sleep and daytime fatigue than are HF.

  • Open Access

    Alleviation of Symptom Burden Following Deep Brain Stimulation in Moderate to Severe Brain Injury

    by Linda M. Gerber, Nancy R. Temkin, Jason Chua, Jason Barber, Jonathan D. Victor, Jaimie M. Henderson, Joseph T. Giacino, Nicholas D. Schiff

    Many patients experience high symptom burden for many years following moderate to severe traumatic brain injury (TBI). Here, we use the Rivermead Post-Concussion Symptoms Questionnaire (RPQ), a self-report questionnaire that tracks the severity of chronic symptoms that impact quality of life, to evaluate longitudinal changes following deep brain stimulation (DBS) in participants with chronic, moderate to severe TBI (msTBI) and to compare findings to the natural recovery observed in the TRACK-TBI Longitudinal cohort. The DBS cohort consisted of the five participants with msTBI in the CENTURY-S trial (CENtral Thalamic Deep Brain Stimulation for the Treatment of Traumatic Brain InjURY, NCT02881151) who received DBS. The total mean RPQ score decreased from 35.0 (SD 8.7) to 18.4 (SD 18.5). 3 participants reporting 10, 8, and 4 symptoms (of a possible 16) as moderate or severe at baseline reported 0 symptoms at this level at treatment end. A fourth participant showed a 50% decrease in the number of moderate to severe symptoms, from 10 to 5. A sample of 107 patients with msTBI from the TRACK-TBI Longitudinal study served as a comparison group. The TRACK-TBI Longitudinal RPQ total score remained stable from 1-year post-injury (mean 13.84. SD 12.61) to the first follow-up at either 2, 3, 4, or ≥5 years post-injury (mean 14.47. SD 12.98). More TRACK-TBI Longitudinal participants experienced worsening moderate to severe symptoms than improvement (increased: N = 44; decreased: N = 28; no change: N = 35). Participants in the CENTURY-S trial with chronic msTBI (3–18 years post injury) achieved marked improvements after DBS in total symptom burden and in the number of symptoms reported as moderate to severe in contrast to participants in the TRACK-Longitudinal sample whose RPQ scores remained stable. These observations suggest that DBS of the central lateral thalamus alleviates chronic TBI-related symptoms, surpassing the natural recovery documented in the TRACK-TBI Longitudinal cohort.

  • Open Access

    External Lumbar Drainage to Abort Severe Traumatic IntraCranial Hypertension Phase 1 Randomized Clinical Trial: Scientific Rationale and Methodology: An MTBI2 Study

    by Halinder S. Mangat, Gregory Hawryluk, Linda M. Gerber, Elizaveta Bokova, Jamshid Ghajar

    BACKGROUND AND OBJECTIVES: There has been renewed interest in the use of external lumbar drainage (ELD) of cerebrospinal fluid (CSF) to reduce intracranial pressure after traumatic brain injury (TBI). Although the evidence is retrospective and thus confounded by selection bias, it is critical that a phase 1 trial systematically identify “select” patients who would gain benefit of intracranial pressure (ICP) reduction from lumbar drainage. The aim of this study is to evaluate safety and feasibility of controlled CSF ELD in reducing ICP burden and improving outcomes of select severe TBI patients. METHODS: The study will include 30 severe TBI patients with a Glasgow Coma Scale score ≤9 who will be randomized to usual treatment, usual treatment plus early ELD placement if initial ICP ≤20 mm Hg, or late ELD if ICP ≥20 mm Hg as first intervention in tier 2 of Seattle International Brain Injury Consensus Consortium protocol. EXPECTED OUTCOMES: It is expected that the incidence of severe neurological worsening events as per Seattle International Brain Injury Consensus Consortium will not be different between the control and intervention groups. DISCUSSION: A multitude of clinical trials to advance or discover new treatments of severe TBI have remained unfruitful. Recent understanding of the glymphatic system in the brain is suggestive that extraventricular CSF drainage may be very useful in reducing ICP. The natural avenue for this is through ELD. To avoid past mistakes by jumping into an advanced stage trial, we intend to conduct a phase 1 safety and feasibility trial to identify ‘select’ patients in whom ELD may be performed safely and may serve as a significant change of therapeutic approach to such patients with traumatic intracranial hypertension.


  • Open Access

    Social Determinants of Health and Delirium in the PICU: Secondary Analysis of a 2014–2015 Observational Dataset

    by Kate Madden, Caroline Andy, Evan T. Sholle, Linda M. Gerber, Chani Traube

    Objectives: To explore the association between geospatial determinants of health and prevalence of delirium in the PICU. Design: Nonprespecified secondary analysis of an observational study dataset. Setting: Urban academic tertiary care PICU. Patients: All children admitted over a 12-month period in 2014–2015. Interventions: None. Measurements and Main Results: Of 1547 admissions, there were individual 1264 patients, with race and ethnicity subgroup recorded for 961 (76%), insurance status for 1240 (98%), and language for 1227 (97%). Child Opportunity Index (COI) was determined by a patient’s 2010 Census Tract and was available for 1246 (98%). Data were grouped from 1 to 5 (very low to very high). PICU delirium (PD) was present in 193 patients during PICU admission, with PD rates highest in Asian/Pacific Islander, Black non-Hispanic, and Hispanic (respectively, 26, 29, and 39 patients) as compared with White non-Hispanic children ( n = 45; p < 0.001). PD was higher for patients with public insurance (113/573 [20%]) compared with those with private insurance (67/583 [12%]) and those with “other” (8/84 [10%]) forms of support ( p < 0.001). We failed to identify a difference in delirium rates by language preference. A higher prevalence of delirium was present among patients in the lowest COI groups (1–3) as compared with highest (4–5; 135/748 [18%] vs. 55/494 [11%]; p = 0.003). In multivariable analysis, COI was associated with greater adjusted odds of delirium (after adjusting for other demographic and clinical predictors of delirium, including age, developmental disability, severity of illness at admission, need for invasive mechanical ventilation, depth of sedation, and medication exposures), with adjusted odds ratio of 1.55 (95% CI, 1.05–2.3; p = 0.028). Conclusions: In a 2014–2015 PICU dataset, we have identified an association between lower COI and greater adjusted odds of delirium. This finding calls for further study to investigate potential mediators of this relationship.


  • Open Access

    Discharge Screening Predicts Persistent Parental Psychological Distress After Pediatric Critical Illness

    by Lynne M. Rosenberg, Gabrielle Silver, Keshia Small, Linda M. Gerber, Chani Traube

    Background/Objectives: Pediatric critical illness constitutes a highly stressful event not only for the critically ill child but also for the broader family unit. Recognizing and addressing these family-level effects is essential to optimizing outcomes for PICU survivors. Methods: This prospective observational cohort study examined anxiety and depression in parents of pediatric ICU patients prior to PICU discharge using the Hospital Anxiety and Depression (HADS) scale, and again after 30 days. At follow-up, parents were also screened for post-traumatic stress symptoms (PTSS) using the Impact of Events (IES) scale. Parent demographics and characteristics of the child’s hospitalization were collected. Results: 235 parents enrolled and completed a HADS; 126 parents (54%) subsequently completed a follow-up HADS and IES. 50% of parents screened positive for anxiety and/or depression prior to discharge; 44% of parents demonstrated anxiety, depression, and/or PTSS on follow-up screening. A positive HADS prior to discharge was the only independent predictor of persistent psychological symptoms. Conclusions: Parental psychological distress is both common and persistent following a child’s PICU admission. Screening at discharge is a feasible method to identify families at the highest risk for enduring anxiety, depression, and post-traumatic stress symptoms.


  • Open Access

    Influence of Distinct Maternal Cytomegalovirus-Specific Neutralizing and Fc Receptor-Binding Responses on Congenital Cytomegalovirus Transmission in HIV-Exposed Neonates

    by Itzayana G. Miller, Aakash Mahant Mahant, Jennifer A. Jenks, Eleanor C. Semmes, Eric Rochat, Savannah L. Herbek, Caroline Andy, Nicole S. Rodgers, Justin Pollara, Linda M. Gerber, et al.

    Congenital cytomegalovirus (cCMV) is the most common infectious cause of birth defects worldwide, affecting approximately 1 in every 200 live-born infants globally. Recent work has identified potential immune correlates of protection against cCMV transmission including maternal and placentally transferred antibody levels and their function, which may inform the development of maternal active (vaccine) and passive (mono/polyclonal antibody) immunizations. However, these correlates need to also be assessed in diverse cohorts, including women living with HIV who have increased risk of cCMV transmission. Using a case–control design, we investigated whether the magnitude, specificity, function and placental transfer of maternal IgG responses are associated with protection against and/or risk of cCMV transmission in HIV/HCMV co-infection. Within 3 historical cohorts of pregnant women with HIV/HCMV co-infection, we identified 16 cCMV transmitting cases that were matched to 29 cCMV non-transmitting controls. Using a systems serology approach, we found that normalized HCMV-specific IgG binding to FcγR1α was higher in non-transmitting dyads, whereas HCMV-neutralizing antibody responses were higher in transmitting dyads. These findings suggest that engagement of FcγR1α by HCMV-specific IgG may help confer protection against cCMV transmission. Building upon previous research, our study reinforces the critical role of validating maternal humoral immune correlates of cCMV transmission risk across diverse seropositive cohorts, providing essential insights to inform and accelerate the development of effective HCMV vaccines.


  • Qualitative Analysis of Symptoms from the Central Thalamic Deep Brain Stimulation Trial for Traumatic Brain Injury

    by Linda M Gerber, Kaiulani S Shulman, Megan S Wright, Nicholas D Schiff, Joseph J Fins

    Background: Studies of moderate-to-severe traumatic brain injury (TBI) report persistent clinical impairment post-injury. In the CENTURY-S study of deep brain stimulation (DBS) in chronic TBI, Schiff et al.‘s paper, “Thalamic deep brain stimulation in traumatic brain injury: a phase 1, randomized feasibility study” demonstrated improvements in executive control. A companion narrative analysis by Fins et al., “Subject and Family Perspectives from the Central Thalamic Deep Brain Stimulation Trial for Traumatic Brain Injury” Parts I and II described improvements in cognitive, behavioral, and emotional capabilities. Objective: The present study provides an aggregate symptom assessment utilizing pre- and post-DBS narratives from subjects and their family members. Methods: Drawing upon participants from the CENTURY-S study, Fins et al. conducted semi-structured interviews with five subjects with moderate-to-severe TBI and their family members. Transcripts were subsequently coded deductively and inductively in Dedoose by two independent investigators. Results: Subjects and families frequently volunteered memory and cognitive symptoms as well as difficulties with self-regulation, frustration, and irritability pre-DBS. Following stimulation, four subjects and four families noted improvement in memory and attention and focus, while three subjects and five families volunteered improvements in self-regulation. Fatigue improved in three subjects who previously reported this symptom and in one who did not. Conclusions: Secondary qualitative analysis of narrative data of DBS trial participants supports the incorporation of qualitative data as additional outcome measures in studies of DBS in TBI.


  • Open Access

    The human cortical motor map in post-stroke hemiparesis in the presence of treatment-related clinically important recovery

    by Tomoko Kitago, Joshua Silverstein, Michael B. Gerber, Charlene Thomas, Linda M. Gerber, Gary W. Thickbroom, Dylan J. Edwards

    Objectives: To determine if intervention-related clinical improvement in post-stroke hemiparesis is associated with enlarged primary motor cortex representation. Methods: Data were analyzed from a single site subset of the NICHE trial. Transcranial magnetic stimulation (TMS) motor mapping was performed in 23 participants (3-12 months post-stroke, 10 female, 40-88 yrs, baseline Fugl-Meyer Upper Extremity (FM-UE) range 13-58) before and after intervention. TMS motor maps were acquired for the extensor digitorum communis muscle (EDC) bilaterally, at 110% resting motor threshold (RMT). Results: Improvement on the primary outcome measure (FM-UE) was statistically and clinically significant (mean pre= 38(±15), post= 45(±16); p 2 , post =109.54(±139.06) mV*mm 2 , p=0.36). The magnitude of clinical benefit was unrelated to difference in map characteristics from pre to post (Spearman’s rho= 0.06, p=0.79). Conclusions: Intervention-related clinical improvement of the upper limb 3-12 months following stroke, was not associated with change in motor cortex excitability or increase in motor maps. Clinical improvements may not solely rely on consistent changes in the cortical motor representation.

  • Bothersome symptoms at midlife in relation to body fat percentage

    by L. M. Gerber, B. W. Whitcomb, M. A. Verjee, L. L. Sievert

    Objectives: Increasing obesity has been associated with a higher frequency of symptoms at midlife. Bothersomeness represents an important measure of perceived symptom severity, but has received relatively little consideration, and relationships between symptom bothersomeness and obesity are not known. We evaluated the association between body fat percentage (%BF) and the bothersomeness of symptoms at midlife.Methods: This cross‐sectional study included women aged 40–60 in Qatar (n = 841). Participants reported frequency and bothersomeness of midlife symptoms hypothesized to be related to body composition. Initially, we characterized the relationship between continuous %BF and presence (yes/no) and bothersomeness (yes/no) for each symptom using restricted cubic spline (RCS) models to test nonlinearity. Subsequently, we used multinomial logistic regressions to evaluate associations between %BF and multilevel symptom outcomes, where categories were: (a) no symptoms or bother, (b) symptoms without bothersomeness, and (c) symptoms with bothersomeness.Results: The highest frequency of bothersomeness was reported for aches/stiffness in joints (51%), followed by trouble sleeping (34%), night sweats (21%), urinary incontinence (18%), hot flashes (16%), and shortness of breath (15%). In unadjusted multinomial logistic regressions, aches/stiffness in joints with and without bothersomeness had the same significant relationship with %BF. Bothersome night sweats, urinary incontinence, and hot flashes were significantly associated with %BF (p < .05), but those same symptoms without bothersomeness were not significantly associated with %BF.Conclusions: Our findings suggest that bothersomeness is an important variable that tracks with body fat and gives different information than report of the presence/absence of a symptom alone.


  • Top Cited Papers

    Thalamic deep brain stimulation in traumatic brain injury: a phase 1, randomized feasibility study

    by Nicholas D. Schiff, Joseph T. Giacino, Christopher R. Butson, Eun Young Choi, Jonathan L. Baker, Kyle P. O’sUllivan, Andrew P. Janson, Michael Bergin, Helen M. Bronte-Stewart, Jason Chua, et al.

    Converging evidence indicates that impairments in executive function and information-processing speed limit quality of life and social reentry after moderate-to-severe traumatic brain injury (msTBI). These deficits reflect dysfunction of frontostriatal networks for which the central lateral (CL) nucleus of the thalamus is a critical node. The primary objective of this feasibility study was to test the safety and efficacy of deep brain stimulation within the CL and the associated medial dorsal tegmental (CL/DTTm) tract. Six participants with msTBI, who were between 3 and 18 years post-injury, underwent surgery with electrode placement guided by imaging and subject-specific biophysical modeling to predict activation of the CL/DTTm tract. The primary efficacy measure was improvement in executive control indexed by processing speed on part B of the trail-making test. All six participants were safely implanted. Five participants completed the study and one was withdrawn for protocol non-compliance. Processing speed on part B of the trail-making test improved 15% to 52% from baseline, exceeding the 10% benchmark for improvement in all five cases. CL/DTTm deep brain stimulation can be safely applied and may improve executive control in patients with msTBI who are in the chronic phase of recovery. ClinicalTrials.gov identifier: NCT02881151.